Slide 1

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Acknowledgements

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Conflicts of interests

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Pseudoprogression

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Case study: 48 y.o. female presented with several day history of increasing left arm and lower facial weakness<br />

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Perfusion MRI appears to solve this diagnostic dilemma

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Pseudoprogession assessed with ferumoxytol

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Ferumoxytol- an iron oxide nanoparticle

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Separation of intravascular and parenchymal contrast enhancement

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 10

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 11

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 12

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Diagnosis of pseudoprogression

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Methods

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 15

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 16

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 17

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Rate of pseudoprogression

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 19

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 20

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Ferumoxytol as MRI contrast agent: orphan-drug designation<br />

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Slide 22

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Take home message

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting

Thank you for your attention!

Presented By Edward Neuwelt at 2014 ASCO Annual Meeting